ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Alum Elicited MDSCs Delay the Rejection of Fully Mistmatched Islets in Mice

A. Cuenca1, N. Feeney2, J. Ge1, K. Deng2, Q. Fu2, G. Huai2, K. Lee2, C. Rickert2, J. Markmann2

1Boston Children's Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA

Meeting: 2020 American Transplant Congress

Abstract number: D-379

Keywords: Inflammation, Islets, Neutrophils

Session Information

Session Name: Poster Session D: Tolerance / Immune Deviation

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Myeloid derived suppressor cells (MDSCs) have been demonstrated to be critical for the induction of tumor induced T cell tolerance and have also been shown to have a role in allograft tolerance. This is thought to be through paracrine effects as well as through the expansion of T regs and B regs. While the majority of cell therapy focus has been on the ex vivo expansion of T regs, we wanted to determine if we could expand these potent suppressor cells in vivo and delay or prevent allograft rejection.

*Methods: To induce MDSCs, C57Bl/6J mice were injected with alum i.p. every other day for 5 days for a total of 3 doses. Spleens were then examined at different time points for the presence of either monocytic MDSCs (M-MDSCs -Ly6C+Cd11b+) or granulocytic MDSCs (G-MDSCs- Ly6G+CD11b+) via flow cytometry. To measure in vitro MDSC induced T cell suppression, spleens from either saline or alum C57Bl/6J mice were harvested and Ly6G and Ly6C MDSC populations were magnetically sorted. CFSE labelled T cells were then stimulated via CD3/CD28 in the presence or not of MDSCs from either saline or alum treated animals. Percent suppression was then measured. We then utilized the islet transplant model to examine the role of MDSCs on allograft rejection. First, we induced diabetes via streptozotocin injection i.p, which was done at Day -4 prior to islet transplant in a separate cohort of animals. Alum injection was then administered on day -5, -3, and -1 prior to islet transplant. To perform the islet transplant, Balb/C islets were isolated and transplanted at day 0 underneath the left kidney capsule of either alum or saline treated C57Bl/6J mice. Glucose and survival were measured

*Results: At 1, 3, and 7 days post alum administration, both the percentage of M-MDSCs and G-MDSCs were significantly higher in alum treated vs saline treated animals. Next, we examined the ability of alum vs saline elicited MDSCs to suppress T cell proliferation in vitro. We demonstrate that MDSCs from alum treated animals were able to significantly suppress CD3/CD28 T cell proliferation by 30% and that this effect was MDSC cell number dependent. To examine whether this expansion of MDSCs observed in alum treated animals could prevent rejection of fully mismatched islets, saline and alum treated C57BL/6 animals underwent islet cell transplant with Balb/C islets. Alum treated animals had significantly increased length of normoglycemia and mean survival compared to saline treated animals, 25 days vs 14 days respectively (p< 0.05).

*Conclusions: We demonstrate that alum elicited MDSCs are potent suppressors of T cell proliferation and can delay rejection of fully mismatched islet grafts up to 3 weeks compared to saline controls. These data suggest that therapeutics designed to expand MDSCs within the transplant recipient could be a useful strategy to decrease the amount of toxic induction and maintenance immunosuppressive regimens we currently employ in our transplant patients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cuenca A, Feeney N, Ge J, Deng K, Fu Q, Huai G, Lee K, Rickert C, Markmann J. Alum Elicited MDSCs Delay the Rejection of Fully Mistmatched Islets in Mice [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/alum-elicited-mdscs-delay-the-rejection-of-fully-mistmatched-islets-in-mice/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences